366 related articles for article (PubMed ID: 29670086)
21. Amplification of hsa-miR-191/425 locus promotes breast cancer proliferation and metastasis by targeting DICER1.
Zhang X; Wu M; Chong QY; Zhang W; Qian P; Yan H; Qian W; Zhang M; Lobie PE; Zhu T
Carcinogenesis; 2018 Dec; 39(12):1506-1516. PubMed ID: 30084985
[TBL] [Abstract][Full Text] [Related]
22. MiR-26b/KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating OCT4.
Lin J; Zhang L; Huang H; Huang Y; Huang L; Wang J; Huang S; He L; Zhou Y; Jia W; Yun J; Luo R; Zheng M
Oncotarget; 2015 Sep; 6(27):23793-806. PubMed ID: 26204489
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-125b Suppresses Ovarian Cancer Progression via Suppression of the Epithelial-Mesenchymal Transition Pathway by Targeting the SET Protein.
Ying X; Wei K; Lin Z; Cui Y; Ding J; Chen Y; Xu B
Cell Physiol Biochem; 2016; 39(2):501-10. PubMed ID: 27383536
[TBL] [Abstract][Full Text] [Related]
24. Recurrent DICER1 hotspot mutations in endometrial tumours and their impact on microRNA biogenesis.
Chen J; Wang Y; McMonechy MK; Anglesio MS; Yang W; Senz J; Maines-Bandiera S; Rosner J; Trigo-Gonzalez G; Grace Cheng SW; Kim J; Matzuk MM; Morin GB; Huntsman DG
J Pathol; 2015 Oct; 237(2):215-25. PubMed ID: 26033159
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-29B (mir-29b) regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3.
Teng Y; Zhang Y; Qu K; Yang X; Fu J; Chen W; Li X
Oncotarget; 2015 Dec; 6(38):40799-814. PubMed ID: 26512921
[TBL] [Abstract][Full Text] [Related]
26. MiR-135a functions as a tumor suppressor in epithelial ovarian cancer and regulates HOXA10 expression.
Tang W; Jiang Y; Mu X; Xu L; Cheng W; Wang X
Cell Signal; 2014 Jul; 26(7):1420-6. PubMed ID: 24607788
[TBL] [Abstract][Full Text] [Related]
27. Recovery of miR-139-5p in Ovarian Cancer Reverses Cisplatin Resistance by Targeting C-Jun.
Jiang Y; Jiang J; Jia H; Qiao Z; Zhang J
Cell Physiol Biochem; 2018; 51(1):129-141. PubMed ID: 30439707
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of miR-874-3p and miR-874-5p inhibits epithelial ovarian cancer malignancy via SIK2.
Xia B; Lin M; Dong W; Chen H; Li B; Zhang X; Hou Y; Lou G
J Biochem Mol Toxicol; 2018 Aug; 32(8):e22168. PubMed ID: 30004169
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-219-5p inhibits the proliferation, migration, and invasion of epithelial ovarian cancer cells by targeting the Twist/Wnt/β-catenin signaling pathway.
Wei C; Zhang X; He S; Liu B; Han H; Sun X
Gene; 2017 Dec; 637():25-32. PubMed ID: 28890378
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-222-3p/GNAI2/AKT axis inhibits epithelial ovarian cancer cell growth and associates with good overall survival.
Fu X; Li Y; Alvero A; Li J; Wu Q; Xiao Q; Peng Y; Hu Y; Li X; Yan W; Guo K; Zhou W; Wang Y; Liu J; Zhang Y; Mor G; Wen J; Yin G
Oncotarget; 2016 Dec; 7(49):80633-80654. PubMed ID: 27811362
[TBL] [Abstract][Full Text] [Related]
31. Functional requirement of dicer1 and miR-17-5p in reactive astrocyte proliferation after spinal cord injury in the mouse.
Hong P; Jiang M; Li H
Glia; 2014 Dec; 62(12):2044-60. PubMed ID: 25043492
[TBL] [Abstract][Full Text] [Related]
32. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
33. MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer.
Zhang Y; Zhao FJ; Chen LL; Wang LQ; Nephew KP; Wu YL; Zhang S
Oncotarget; 2014 Dec; 5(23):12291-303. PubMed ID: 25460499
[TBL] [Abstract][Full Text] [Related]
34. MiR-363 inhibits cisplatin chemoresistance of epithelial ovarian cancer by regulating snail-induced epithelial-mesenchymal transition.
Cao L; Wan Q; Li F; Tang CE
BMB Rep; 2018 Sep; 51(9):456-461. PubMed ID: 30037365
[TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA CCAT1 promotes metastasis and poor prognosis in epithelial ovarian cancer.
Cao Y; Shi H; Ren F; Jia Y; Zhang R
Exp Cell Res; 2017 Oct; 359(1):185-194. PubMed ID: 28754469
[TBL] [Abstract][Full Text] [Related]
36. miRNA-34a decreases ovarian cancer cell proliferation and chemoresistance by targeting HDAC1.
Lv T; Song K; Zhang L; Li W; Chen Y; Diao Y; Yao Q; Liu P
Biochem Cell Biol; 2018 Oct; 96(5):663-671. PubMed ID: 29561664
[TBL] [Abstract][Full Text] [Related]
37. miR-215 functions as a tumor suppressor in epithelial ovarian cancer through regulation of the X-chromosome-linked inhibitor of apoptosis.
Ge G; Zhang W; Niu L; Yan Y; Ren Y; Zou Y
Oncol Rep; 2016 Mar; 35(3):1816-22. PubMed ID: 26676658
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of microRNA-383 has tumor suppressive effect in human epithelial ovarian cancer through the action on caspase-2 gene.
Liu J; Dou Y; Sheng M
Biomed Pharmacother; 2016 Oct; 83():1286-1294. PubMed ID: 27567588
[TBL] [Abstract][Full Text] [Related]
39. Reversal of cisplatin resistance by microRNA-139-5p-independent RNF2 downregulation and MAPK inhibition in ovarian cancer.
Chen Y; Cao XY; Li YN; Qiu YY; Li YN; Li W; Wang H
Am J Physiol Cell Physiol; 2018 Aug; 315(2):C225-C235. PubMed ID: 29719173
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-520g promotes epithelial ovarian cancer progression and chemoresistance via DAPK2 repression.
Zhang J; Liu L; Sun Y; Xiang J; Zhou D; Wang L; Xu H; Yang X; Du N; Zhang M; Yan Q; Xi X
Oncotarget; 2016 May; 7(18):26516-34. PubMed ID: 27049921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
